Advanced Therapy in Hypertension and Vascular DiseaseAdvanced Therapy in Hypertension and Vascular Diseaseis intended as a clinical resource for health care professionals who evaluate and manage patients with hypertension with its many forms and challenges. The authors have endeavored to provide brief, focused chapters so that busy practitioners can find the information they need quickly when confronted with specific hypertension symptoms and presentations. The text covers specific management issues for all aspects of cardiac disease and hypertension including: lifestyle factors, HRT, sleep apnea, psychic and cerebrovascular problems, genetic screening, current teaching guidelines, medical genetics, and blood pressure management. The final section reviews practical aspects for those who teach in hypertension scenarios. The appendices round off the book providing standard reference tables from current guidelines. As with all titles in the Advanced Therapy Series, this book compliments traditional textbooks by offering expert treatment therapies from seasoned clinicians. |
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
PERSPECTIVE ON THE NEW TERMINOLOGY AND DEFINITIONS OF HYPERTENSION AND INTERVENTION WITH LIFESTYLE MEASUR... | 1 |
OFFSPRING OF HYPERTENSIVE PATIENTS | 13 |
OVERVIEW OF THE HYPERTENSIVE PATIENT | 17 |
OVERVIEW OF DISEASE MANAGEMENT PRINCIPLES | 21 |
OVERVIEW OF HYPERTENSION CARE FROM NONPHYSICIAN PROVIDERS | 30 |
HYPERTENSION IN ASIA | 38 |
HYPERTENSION IN AFRICANS | 48 |
HYPERTENSION IN ADOLESCENTS | 58 |
POLYCYSTIC OVARY SYNDROME | 421 |
IMPORTANT PHARMACOLOGY PRINCIPLES IN MANAGING THE COMPLICATED HYPERTENSIVE | 431 |
COARCTATION OF THE AORTA | 440 |
THE IMPACT OF ESTROGEN ON BLOOD PRESSURE | 446 |
HYPERTENSION IN SPECIAL CLINICAL SITUATIONS THE PATIENT WITH END STAGE RENAL DISEASE | 452 |
MANAGEMENT OF HYPERTENSIVE EMERGENCIES | 458 |
HYPERTENSION AND COCAINE AND AMPHETAMINES | 466 |
ERYTHROPOIETININDUCED HYPERTENSION | 474 |
TREATMENT OF HYPERTENSION IN THE ATHLETE | 74 |
HYPERTENSION AND WEIGHT LOSS | 83 |
SALT AND DIETARY CHANGE TO CONTROL BLOOD PRESSURE | 89 |
EXERCISE AND HYPERTENSION | 99 |
ALCOHOL AND HYPERTENSION | 108 |
HYPERTENSIVE RETINOPATHY AND RETINAL VASCULAR DISEASES | 118 |
BLOOD PRESSURE LOWERING IN PATIENTS WITH A PREVIOUS STROKE | 130 |
ATRIAL FIBRILLATION AND HYPERTENSION | 136 |
SPONTANEOUS HEMORRHAGIC STROKE | 143 |
HYPERTENSION AND LACUNAR STROKE | 152 |
HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE | 161 |
HYPERTENSION WITH HEART FAILURE | 169 |
PERIPHERAL ARTERIAL DISEASE AND HYPERTENSION | 176 |
AORTIC ANEURYSM | 180 |
THORACIC AORTA DISSECTION | 192 |
EVALUATION AND TREATMENT OF PATIENTS WITH HYPERTENSION AND CAROTID ATHEROSCLEROSIS | 198 |
LEFT VENTRICULAR HYPERTROPHY BY ELECTROCARDIOGRAPH ECHOCARDIOGRAPHY OR OTHER IMAGING | 206 |
THE TACHYCARDIC HYPERTENSIVE PATIENT | 218 |
ABDOMINAL BRUITS IN PATIENTS WITH HYPERTENSION | 224 |
HYPERTENSION AND CORONARY ARTERY CALCIFICATION | 232 |
AN INCIDENTALLY DISCOVERED ADRENAL MASS | 238 |
ADRENAL VEIN SAMPLING IN THE EVALUATION OF HYPERALDOSTERONISM | 245 |
ROLE OF MAGNETIC RESONANCE IMAGING IN DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH RENAL ARTERY STENOSIS | 251 |
HYPERTENSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE MANIFESTED BY ELEVATED SERUM CREATININE | 262 |
MlCROALBUMINURIA | 268 |
PROTEINURIA IN HYPERTENSION IMPLICATIONS FOR PROGNOSIS AND THERAPY | 282 |
ABNORMAL POTASSIUM | 291 |
CALCIUM AND HYPERTENSION | 300 |
PHEOCHROMOCYTOMA AND PARAGANGLIOMA | 309 |
ELEVATED ALDOSTERONE RENIN RATIO | 321 |
PLASMAFREE METANEPHRINES AND BIOCHEMICAL DIAGNOSIS OF PHEOCHROMOCYTOMA | 329 |
THE HYPERTENSIVE PATIENT WITH LABORATORY FINDINGS ROLE OF CORTISOL | 338 |
CONGENITAL ADRENAL HYPERPLASIA AND HYPERTENSION | 347 |
TREATMENT OF HYPERTENSION AND THYROID DISEASE | 354 |
HYPERTENSION LIPOPROTEIN ABNORMALITIES AND THE METABOLIC SYNDROME | 361 |
ESSENTIAL HYPERTENSION DURING PREGNANCY | 383 |
PREECLAMPSIA | 394 |
ECLAMPSIA | 407 |
HYPERTENSION ELEVATED LIVER ENZYMES AND LOW PLATELETS HELLP | 416 |
IMMUNOSUPPRESSION | 483 |
CYCLOOXYGENASE INHIBITION AND BLOOD PRESSURE REGULATION | 492 |
HYPERTENSION AND CANCER CHEMOTHERAPIES | 502 |
OBSTRUCTIVE SLEEP APNEA | 508 |
HYPERTENSION AND PRIMARY PSYCHIATRIC DIAGNOSIS | 518 |
SYSTOLIC HYPERTENSION IN THE ELDERLY | 527 |
WHITE COAT HYPERTENSION AND WHITE COAT WORSE HYPERTENSION | 537 |
MANAGEMENT OF HYPERTENSION IN DIABETES | 544 |
DIABETES COMPLICATED BY NEPHROPATHY | 555 |
MANAGEMENT OF SUPINE HYPERTENSION IN THE PATIENT WITH ORTHOSTATIC HYPOTENSION | 567 |
AUTONOMIC DYSFUNCTION SYNDROMES ORTHOSTATIC HYPOTENSION AND ORTHOSTATIC TACHYCARDIA | 575 |
AMBULATORY BLOOD PRESSURE MONITORING ITS USE IN CLINICAL PRACTICE AND IMPLICATIONS FOR THERAPY | 585 |
THE ROLE OF SELFMEASURED HOME BLOOD PRESSURE MEASUREMENT | 591 |
SEXUAL DYSFUNCTION IN HYPERTENSIVE PATIENTS | 597 |
TREATMENT ADHERENCE AND HYPERTENSION MANAGEMENT | 604 |
DRUGRESISTANT HYPERTENSION | 614 |
PAROXYSMAL HYPERTENSION | 624 |
WHEN SHOULD GENETIC SCREENING BE CONSIDERED? | 633 |
GLUCOCORTICOIDREMEDIABLE ALDOSTERONISM | 639 |
FAMILIAL PHEOCHROMOCYTOMA AND PARAGANGLIOMA | 644 |
KIDNEY DISEASE GENES AND HYPERTENSION | 652 |
VON HIPPELLINDAU DISEASE PHEOCHROMOCYTOMAS AND HYPERTENSION | 660 |
MEDICAL THERAPY OF RENOVASCULAR HYPERTENSION | 669 |
PERCUTANEOUS INTERVENTIONAL MANAGEMENT OF RENAL VASCULAR DISEASE | 678 |
MULTIPLE ENDOCRINE NEOPLASIA | 687 |
HYPERTENSION AFTER NONCARDIAC VASCULAR SURGERY | 690 |
SUBARACHNOID HEMORRHAGE | 702 |
HYPERTENSION AND ACUPUNCTURE | 712 |
TREATMENT OF HYPERTENSION WITH NUTRACEUTICALS VITAMINS ANTIOXIDANTS AND MINERALS | 719 |
PATIENT EDUCATION RESOURCES | 726 |
HYPERTENSION AND THE INTERNET A PRIMER | 735 |
PREPARING TO GIVE A HYPERTENSION LECTURE | 741 |
BLOOD PRESSURE CLASSIFICATION IN ADULTS | 746 |
TARGET ORGAN DAMAGE IN HYPERTENSION | 747 |
TABLE OF CURRENT ANTIHYPERTENSIVE AGENTS | 748 |
| 750 | |
| 753 | |
Other editions - View all
Common terms and phrases
ACE inhibitors activity acute addition adrenal agents alcohol American aneurysm antihypertensive aortic artery assessment associated blockers blood pressure calcium cardiac cardiovascular cause cell changes chronic Circulation Clin clinical compared coronary decrease Detection diabetes diagnosis diastolic disease diuretics dose drug effects elevated et al Evaluation evidence exercise factors Figure function glucose Health heart heart failure higher hyper hypertension hypertensive patients hypothyroidism imaging important improve incidence increased indicated individuals initial Intern kidney left ventricular less levels lower mass measurements medications mortality myocardial infarction normal observed occur outcomes patients plasma population preeclampsia prevalence Prevention primary ramipril randomized reduction renal reported response risk risk factors role severe showed significant sion sodium stroke subjects suggest syndrome systolic Table therapy tion treated treatment trial urinary usually vascular weight women
Bibliographic information
| Title | Advanced Therapy in Hypertension and Vascular Disease Pmph USA Ltd Series |
| Editor | Emile R. Mohler (III.) |
| Contributor | Raymond R. Townsend |
| Publisher | PMPH-USA, 2006 |
| ISBN | 1550093185, 9781550093186 |
| Length | 770 pages |
| Export Citation | BiBTeX EndNote RefMan |